LY-3381916

SynDRA canonical compound SYN0040226 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	IDO1
Mechanism of action	indoleamine 2,3-dioxygenase inhibitor
Indication	renal cell carcinoma (rcc)
Disease area	oncology

Cross-references

PubChem CID: 132209614
ChEMBL: CHEMBL4778760

Synonyms

Ly3381916
LY3381916
RefChem:925044
IDO1 Inhibitor LY3381916
IDO-1 Inhibitor LY3381916
IDO1-IN-5
(R)-IDO1-IN-5
C23H25FN2O3
orb1309461
SCHEMBL19689648
GLXC-22563
EX-A4934
RLD61675
BDBM50562497
NSC817042
s8919
AKOS040733638
NSC-817042
AC-36897
DA-55112
MS-26689
HY-111540
CS-0087014
LY-3381916?
G16623
T11901

Look up LY-3381916 in the interactive SynDRA portal →